Showing results (251-260 of 276) with videos related to
Sort By:
Pageof 28
Journal of Applied Microbiology|October 11, 2020
Effects of Lactobacillus hilgardii 4785 and Lactobacillus buchneri 40788 on the bacterial community, fermentation and aerobic stability of high-moisture corn silageE B da Silva, M L Smith, R M Savage, et al.The Journal of Nutrition|August 25, 1999
Delayed changes in postprandial lipid in young normolipidemic men after a nocturnal vitamin A oral fat load testS Hadjadj, J L Paul, L Meyer, et al.Clinical Chemistry|September 3, 1999
Increased ability of LDL from normolipidemic type 2 diabetic women to generate peroxidesB Guerci, H Antebi, L Meyer, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 30, 2000
Lack of relationship in long-term type 1 diabetic patients between diabetic nephropathy and polymorphisms in apolipoprotein epsilon, lipoprotein lipase and cholesteryl ester transfer protein. Genétique de la Nephropathie Diabétique Study Group. Données Epidémiologiques sur le Syndrome d'Insulino-Résistance Study GroupS Hadjadj, Y Gallois, G Simard, et al.Diabetes & Metabolism|September 8, 2001
Analysis of the postprandial lipid metabolism: use of a 3-point testB Guerci, J L Paul, S Hadjadj, et al.Diabetes Care|March 1, 1989
Visual evoked potentials in diabetic patientsM Algan, O Ziegler, P Gehin, et al.Annals of Nutrition & Metabolism|January 1, 1997
Low-density lipoprotein ability to generate lipoperoxides in healthy subjects: variations according to ageH Tronel, H Antebi, F Felden, et al.Gynecologic Oncology|September 1, 1995
Laparoscopic staging of early ovarian cancerC Pomel, D Provencher, J Dauplat, et al.Atherosclerosis|February 1, 1996
Apo B-containing lipoprotein particles in poorly controlled insulin-dependent diabetesB Igau, S Lestavel, V Clavey, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
Cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in advanced ovarian cancer: a randomized phase III study of the National Cancer Institute of Canada Clinical Trials GroupK Swenerton, J Jeffrey, G Stuart, et al.Pageof 28